000756 新华制药
2024/03 -
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资59,7612.03%58,57257,15456,70757,796
投资性房地产33,123-2.32%33,90948,35445,76650,017
固定资产3,239,268-2.61%3,325,9453,447,8893,195,1123,117,313
在建工程828,51613.41%730,545545,895562,959416,990
无形资产490,242-0.95%494,937474,107466,451449,247
商誉0--0000
其他非流动资产338,4613.21%327,925234,432251,080314,718
4,989,3720.35%4,971,8334,807,8314,578,0754,406,081

流动资产
货币资金922,0540.41%918,3341,158,742744,662855,771
应收账款1,059,58451.40%699,878761,259658,568379,909
存货1,133,131-13.70%1,312,9841,211,9871,027,5401,124,364
其他流动资产363,837-5.04%383,138324,971323,188326,827
3,478,6064.96%3,314,3343,456,9592,753,9582,686,871

流动负债
短期借款254,419-10.40%283,959118,023269,455200,420
应付票据505,943-1.07%511,431491,025405,072289,973
应付帐款643,224-3.48%666,413599,056661,320452,930
其他流动负债1,037,4861.30%1,024,1981,950,3821,166,0341,437,716
2,441,072-1.81%2,486,0003,158,4862,501,8802,381,039
流动资产净值1,037,53425.26%828,333298,474252,078305,832
资产总额减流动负债6,026,9053.91%5,800,1665,106,3054,830,1534,711,913

非流动负债
长期借款796,700-0.34%799,400545,656346,197462,738
应付债券0--0000
其他非流动负债239,2446.32%225,013211,085832,812857,885
1,035,9441.13%1,024,413756,7411,179,0081,320,623

总权益
    实收股本682,4081.14%674,683669,627627,367621,859
    储备项目4,082,5115.26%3,878,4213,456,6472,840,5742,601,934
股东权益4,764,9194.65%4,553,1044,126,2743,467,9423,223,794
非控股权益226,0421.52%222,649223,290183,203167,496